A Phase 2, Single-blind, Randomized, Placebo-controlled Study to Evaluate the Safety and Microbiology of C16G2 Varnish Administered in Multiple Doses to Adolescent and Adult Dental Subjects
Phase of Trial: Phase II
Latest Information Update: 22 Jun 2017
At a glance
- Drugs C 16G2 (Primary)
- Indications Dental caries
- Focus Adverse reactions
- Sponsors C3J Therapeutics
- 14 Jun 2017 Status changed from active, no longer recruiting to completed.
- 04 May 2017 Planned End Date changed from 1 Apr 2017 to 1 May 2017.
- 21 Mar 2017 Status changed from not yet recruiting to active, no longer recruiting.